743P A phase Ib dose escalation study of CD137 mAb agonist OC-001 as monotherapy in patients with advanced or metastatic cancer

Autor: Miller, W.H., Provencher, D., Chu, Q.S-C., Jonker, D., Oza, A.M., Batist, G., Jamal, R., Goel, R., Hilton, J.F., Spratlin, J., Smith, P., Darling, I., Stille, J., Fortier, C., Mangat, R., Polzer, J.
Zdroj: In Annals of Oncology September 2022 33 Supplement 7:S884-S884
Databáze: ScienceDirect